Last $0.39 USD
Change Today +0.0588 / 17.86%
Volume 16.9M
NSPH On Other Exchanges
NSPH is not on other exchanges.
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

nanosphere inc (NSPH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/7/14 - $2.62
52 Week Low
01/26/15 - $0.22
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOSPHERE INC (NSPH)

Related News

No related news articles were found.

nanosphere inc (NSPH) Related Businessweek News

No Related Businessweek News Found

nanosphere inc (NSPH) Details

Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment, and enhanced healthcare economics. It offers a molecular diagnostics platform, Verigene System platform that enables clinicians to identify and treat the bacteria and viruses for complex, costly, and deadly infectious diseases. The Verigene System includes a bench-top molecular diagnostics workstation for genomic and protein testing. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive protein assays. The company focuses on serving hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois.

169 Employees
Last Reported Date: 02/11/15
Founded in 1998

nanosphere inc (NSPH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $330.0K
Chief Strategy Officer
Total Annual Compensation: $211.0K
Compensation as of Fiscal Year 2013.

nanosphere inc (NSPH) Key Developments

Nanosphere, Inc. Reports Unaudited Earnings Results for the Year Ended December 31, 2014; Provides Revenue Guidance for the Year Ending December 31, 2015

Nanosphere, Inc. reported unaudited earnings results for the year ended December 31, 2014. For the year, the company reported total revenue of $14,290,000 compared to $10,002,000 a year ago. Loss from operations was $37,690,000 compared to $33,721,000 a year ago. Net loss and comprehensive loss was $39,070,000 or $0.47 per basic and diluted share compared to $34,647,000 or $0.56 per basic and diluted share a year ago. This 43% growth of year-over-year revenue growth was driven predominantly by U.S. based microbiology laboratories continued adoption of blood culture BCGP and BCGN tests. Cash used in operations of $34.9 million for the year ended December 31, 2014 was up $0.9 million as compared to $34.0 million at December 31, 2013 due to a slightly higher net operating loss. For the fiscal year ending December 31, 2015, the company currently expects to recognize between $18 million to $20 million in annual revenue.

Nanosphere, Inc. Auditor Raises 'Going Concern' Doubt

Nanosphere, Inc. filed its 10-K on Feb 11, 2015 for the period ending Dec 31, 2014. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Nanosphere, Inc. to Report Q4, 2014 Results on Feb 11, 2015

Nanosphere, Inc. announced that they will report Q4, 2014 results on Feb 11, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSPH:US $0.39 USD +0.0588

NSPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GenMark Diagnostics Inc $12.98 USD +0.27
Great Basin Scientific Inc $2.79 USD -0.01
Luminex Corp $16.09 USD +0.35
Meridian Bioscience Inc $20.04 USD +0.24
Quidel Corp $26.41 USD +0.73
View Industry Companies

Industry Analysis


Industry Average

Valuation NSPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSPHERE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at